Currently, there are 464.50M common shares owned by the public and among those 455.18M shares have been available to trade.
The company’s stock has a 5-day price change of 18.00% and 19.44% over the past three months. VIPS shares are trading -11.43% year to date (YTD), with the 12-month market performance down to -1.19% lower. It has a 12-month low price of $11.50 and touched a high of $20.19 over the same period. VIPS has an average intraday trading volume of 4.03 million shares. The stock is trading above its simple moving averages at the SMA20, SMA50, and SMA200, as the current price level is off by 19.09%, 18.51%, and 1.93% respectively.
3 Tiny Stocks Primed to Explode
The world's greatest investor — Warren Buffett — has a simple formula for making big money in the markets. He buys up valuable assets when they are very cheap. For stock market investors that means buying up cheap small cap stocks like these with huge upside potential.
We've set up an alert service to help smart investors take full advantage of the small cap stocks primed for big returns.
Click here for full details and to join for free
Sponsored
Institutional ownership of Vipshop Holdings Ltd ADR (NYSE: VIPS) shares accounts for 69.31% of the company’s 464.50M shares outstanding.
It has a market capitalization of $7.17B and a beta (3y monthly) value of 0.33. The stock’s trailing 12-month PE ratio is 7.47, while the earnings-per-share (ttm) stands at $2.10. The company has a PEG of 1.60 and a Quick Ratio of 1.11 with the debt-to-equity ratio at 0.08. Price movements for the stock have been influenced by the stock’s volatility, which stands at 6.06% over the week and 3.20% over the month.
Earnings per share for the fiscal year are expected to decrease by -4.40%, and 4.99% over the next financial year. EPS should shrink at an annualized rate of 4.66% over the next five years, compared to 33.15% over the past 5-year period.
Looking at the support for the VIPS, a number of firms have released research notes about the stock. UBS stated their Neutral rating for the stock in a research note on August 21, 2024, with the firm’s price target at $20-$12.50. The Benchmark Company was of a view on May 23, 2024 that the stock is Hold, while Citigroup gave the stock Buy rating on January 23, 2024, issuing a price target of $20- $21. Citigroup on their part issued Buy rating on November 15, 2023.
